Completed NA INTERVENTIONAL 2-arm NCT00911794

Written Disclosure Therapy for Anxiety and Stress in Patients With Chronic Lung Disease

Pulmonary Therapy and Supplemental Written Disclosure Therapy for Chronic Lung Disease

Sponsor: Stony Wold-Herbert Fund, Inc.

Conditions COPD Chronic Lung Diseases Pulmonary Fibrosis

Interventions Disclosure Writing (Written Disclosure Therapy) Neutral (Sham) Writing

Updated 6 times since 2017 Last updated: Jun 1, 2009 Started: Jan 31, 2007 Primary completion: Jan 31, 2008 Completion: Mar 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on COPD and Chronic Lung Diseases, this trial is completed. The trial is conducted by Stony Wold-Herbert Fund, Inc. and has accumulated 6 data snapshots since 2007. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Jan 2026 — Present [monthly]

Completed NA
Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stony Wold-Herbert Fund, Inc.
Winthrop University Hospital

Data source: Winthrop University Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.